DaVita Clinical Research (DCR) acts as the bridge between DaVita services and the pharmaceutical and biotech research community. Established in 1994, it provides comprehensive multi-specialty (Phase II-III) clinical trial services to the pharmaceutical and biotech industry. DCR has an extensive track record, having conducted more than 500 clinical trials with over 175 pharmaceutical companies. Based in the United States, DCR's focus on Biotechnology and Healthcare contributes to its significance in the industry. While the organization's commitment to aiding scientists and doctors in finding cures is substantial, they rely on collaborative support to further their impact. Currently, there is no information available regarding recent investments or involved investors.
General Information
Get notified when DaVita Clinical Research moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track DaVita Clinical Research
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
United States Market
Biotechnology
About DaVita Clinical Research
No funding data available for DaVita Clinical Research yet.
Get notified when DaVita Clinical Research raises fundingDaVita Clinical Research Alternatives & Competitors
Driving Science Forward
International CRO elevating the standards of pharmacovigilance, regulatory affairs and clinical rese...
FAQ About DaVita Clinical Research
Don't just browse. Track.
Signal Tracker monitors DaVita Clinical Research and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.